Adicción a la efedrina en los trastornos psiquiátricos

Efrén Martínez-Quintana, Fayna Rodríguez- González


No existe.

Palabras clave

No existe.

Texto completo:



Astrup, A., Buemann, B., Christensen, N. J., Toubro, S., Thorbek, G., Victor, O. J. et al. (1992). The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism 41, 686-8.

Maglione. M., Miotto, K., Iguchi, M., Jungvig, L., Morton, S. C. y Shekelle,

P. G. (2005). Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events. American Journal of Psychiatry 162,189-91.

Martínez-Quintana, E., Rodríguez-González, F. y Cuba-Herrera, J. (2010).

Myocardial necrosis and severe biventricular dysfunction in the context of chronic ephedrine abuse. Adicciones, 22: 25-8.

Miller, S. C. Psychiatric effects of ephedra: addiction (2005). American

Journal of Psychiatry 162, 2198.

Miller, S. C. y Waite, C. (2003) Ephedrine-type alkaloid-containing

dietary supplements and substance dependence. Psychosomatics 44, 508-11.

Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A.,

Suttorp, M. J. et al. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a metaanalysis. JAMA 289, 1537-1545.

White, L. M., Gardner, S. F., Gurley, B. J., Marx, M. A., Wang, P. L. y

Estes, M. (1997). Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. Journal of Clinical Pharmacology, 37:116-22.

Wooltorton, E. y Sibbald, B. Ephedra/ephedrine: cardiovascular and CNS

effects (2002) CMAJ, 166: 633.


Enlaces refback

  • No hay ningún enlace refback.